Rhumbline Advisers Roivant Sciences Ltd. Transaction History
Rhumbline Advisers
- $103 Billion
- Q1 2024
A detailed history of Rhumbline Advisers transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Rhumbline Advisers holds 957,349 shares of ROIV stock, worth $10.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
957,349
Previous 421,641
127.05%
Holding current value
$10.1 Million
Previous $4.74 Million
113.09%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding ROIV
# of Institutions
263Shares Held
489MCall Options Held
565KPut Options Held
1.68M-
Sb Investment Advisers (Uk) LTD London, X073MShares$771 Million7.6% of portfolio
-
Viking Global Investors LP69.4MShares$733 Million2.78% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$705 Million65.04% of portfolio
-
Black Rock Inc. New York, NY36.2MShares$382 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.6MShares$376 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.44B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...